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Background: Complementary and alternative medicine (CAM) is commonly used in China for the management of
coronary artery disease (CAD). However, few studies have been conducted to investigate the prevalence, perceived
effectiveness, types, and reasons of CAM use in patients diagnosed with CAD.
Methods: A cross-sectional study design was adopted. Questionnaires were distributed at the outpatient cardiac
clinics of four tertiary-level teaching general hospitals in Beijing. Quantitative data were analyzed using Student’s
t-test. Categorical data were analyzed using chi-square test. Logistic regression was employed to explore factors
associated with the use of CAM as well as CAM use features in Chinese medicine (CM) hospitals when significant
differences were found upon comparisons.
Results: From May to July, 2009, a total of 600 questionnaires were distributed, and 546 patients with a diagnosis
of CAD responded with valid values and were included in the present study. CAM was used by 69.1% of the
patients with CAD; the majority (75.9%) of these CAM users believes that CAM is effective. “Few side effects” (49.6%)
was the main reason of CAM use; whereas “doubt of effect” (61.5%) was the main reason for non-use. Patent herbal
medicine (90.7%) was the most commonly used CAM type. Compared with non-CAM users, CAM users tended to
be older (p < 0.01), have a longer disease duration (p = 0.02) and better current health status. In addition, CAM users
had significant lower odds for emergency admission and hospitalization within the past one year. Patients with
CAD from CM and WM hospitals differ in CAM use frequency, types, perceived effectiveness, as well as reasons for
CAM use or non-CAM use.
Conclusion: The present study suggested a group of significant factors which could influence the use of CAM in
patients with CAD. CAM use patterns differ in patients from CM and WM hospitals.
Keywords: CAM use, CAD, Cross sectional study, Patent herbal medicineBackground
Coronary artery disease (CAD) is the inflammatory result
of the accumulation of atheromatous plaques within the
walls of the coronary arteries which supply the heart with
oxygen and nutrients [1]. Manifestations of CAD may in-
clude asymptomatic CAD, stable angina, unstable angina,
acute myocardial infarction (MI), and sudden death. With
the transition of people’s life style and prevalence of west-
ernized diet, coronary artery disease (CAD) has become* Correspondence: fuyongchu@gmail.com; lhx_@263.net
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reproduction in any medium, provided the orone of the most prevalent health problems worldwide [2].
CAD is the leading cause of death in the United States
and the second leading cause of cardiovascular death in
China [3,4]. In both countries which have the world’s
largest economies, the prevalence and impact of CAD
are expected to grow [3-5]. Management of CAD typically
consists of smoking cessation, blood pressure control, lipid
management, physical activity, weight management, and
treatment of concomitant disorders [2]. However, even
with the most up-to-date management including interven-
tional or surgical techniques which have largely decreased
the mortality of CAD, quality of life of these patients needs
to be further addressed [5-7]. In addition, the direct care. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ivity of the disease impose enormous economic burden
on families, societies, and the public health system of
countries [8,9].
Complementary and alternative medicine (CAM) which
is defined as health care practices or interventions which
are not taught in conventional biomedical schools is com-
monly used by the general population all over the worlds
[10]. Based on epidemiological studies, an increasing trend
in CAM use exists in the United States [10], England [11],
Canada [12-14], Australia [15], Israel [16], and South
Africa [17]. Recent studies also confirmed the use of
CAM in patients with CAD. Decker et al. [18] reported
that 19% patients with acute coronary syndrome used
CAM, and higher proportions of patients who used CAM
were non-Caucasian, uninsured, economically burdened,
and had depression. Prasad et al. [19] reported that 75.4%
patients with cardiovascular disease used dietary supple-
ments, 31.5% chiropractic therapy, 23.9% mind-body
therapies, and 19.2% massage; however, only 14.4% had
discussed the use of CAM treatments with their physi-
cians. Grant et al. [20] summarized 27 studies regarding
CAM use by patients with cardiovascular disease and
found that CAM use in cardiac patients ranged from 4% -
61% with biologically-based therapies usage ranging from
22% to 68% and herbal medicines ranging between 2% and
46%. The heterogeneity of the results in those studies
indicates that CAM use in patients varies in different
countries, cities, ethnicities, specific CAM modalities,
and patients’ economic status.
CAM therapies are commonly categorized into the
following categories: whole medical systems, mind-body
medicine, biologically based practices, manipulative and
body-based therapies and energy medicine [21]. Trad-
itional Chinese Medicine (TCM) which includes herbal
medicine, acupuncture, qigong, and tai chi originated
from China. Components of TCM may fit into one or
several of CAM categories, for example, qigong may be
regarded as an energy medical therapy, and Chinese
herbal medicine may be perceived as the whole medical
systems. As a requirement by Chinese government pol-
icies, acupuncture and herbal medicine are offered in the
Departments of Acupuncture and/or Chinese Medicine
(CM) inside almost every western medicine (WM) hospi-
tals. Meanwhile, a large number of CM hospitals where al-
most all patients receive CM therapy exist in China. TCM
has been used in China for the management of CAD for
more than two thousand years. However, few studies have
been conducted to investigate the prevalence, perceived
effectiveness, types, and reasons of CAM use in patients
diagnosed with CAD in China. In addition, to our best
knowledge, no studies have been performed to explore the
differences of CAM use between patients visiting CM and
WM hospitals. Therefore, the aims of the present studywere to: (1) determine the prevalence, perceived effective-
ness, types, and reasons of CAM use in patients diagnosed
with CAD in Beijing; (2) investigate the possible differ-
ences between CAM users and non-CAM users; (3) ex-
plore possible different CAM use features between CM
and WM hospitals.
Methods
Study design and setting
After approval from the Human Research Committees at
Guang An Men Hospital, An Zhen Hospital, Xi Yuan
Hospital, and Xuan Wu Hospital, the present cross-
sectional study was performed at the outpatient cardiac
clinics of these four tertiary-level teaching general hospi-
tals in Beijing, north China. The method of verbal in-
formed consent only was approved by the hospital ethics
committees. Although the Chinese population is exposed
to the same Chinese culture, the majority of patients may
be more likely to go to CM hospitals for CAM treatments.
As the goal of the study is to capture the characteristics of
CAM use in patients with CAD and compare the possible
differences in CAM use between CM and WM hospitals,
surveys were distributed simultaneously at two out of five
tertiary-level CM hospitals and two out of 30 tertiary-level
WM hospitals in Beijing. The two CM hospitals of Guang
An Men Hospital and Xi Yuan Hospital are well-known
by local Chinese for their CM treatment of CAD; whereas
the two WM hospital of An Zhen Hospital and Xuan Wu
Hospital are well-known by local Chinese for their WM
treatment of CAD. At the outpatient cardiac clinic in each
of the four hospitals, 150 CAD consecutive patients were
approached and a verbal informed consent was gained
from patients prior to participation. Patients were then
instructed to complete the questionnaire at the clinic.
Patients who filled the questionnaire before and patients
who were illiterate were excluded at the site of survey. In
addition, patients who used CAM for other purposes
besides the management of CAD were also excluded.
Diagnostic criteria of CAD
In the present study, CAD was defined as stable angina
(SA), unstable angina (UA) and myocardial infarction (MI,
including non-ST-elevation MI, ST-elevation MI, and old
MI). The diagnostic criteria were based on the recommen-
dations of the latest guidelines of American College of
Cardiology and American Heart Association (ACC/AHA)
[22-24]. All the patients were over 18 years old without
any language or neurological disorders that may prevent
them from voluntary participation in the study.
Contents of the questionnaire
The questionnaire composed of two parts with 21
questions in total. Part One recorded the following
three domains: (1) demographic characteristics of the
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and monthly household income); (2) CAD-related infor-
mation (CAD types, duration, concomitant disorders,
emergency admission or hospitalization within the past
one year), and (3) CAM use characteristics (types, fre-
quency, perceived effectiveness, reasons for use or non-
use). Part Two recorded patients’ current health status via
the Chinese version of Seattle Angina Questionnaire
(SAQ), which had a good reliability and validity in Chinese
patients [25]. Translation of Questions in Part One of the
questionnaire includes:
1. What is the pattern (type) of your CAD? (done by the
researchers as per patient reports and acquisition of
patients’ medical history when necessary)
2. How long have you had CAD?
3. Do you have any concomitant disorders? If yes, what
are they?
4. Have you ever had any emergency admission or
hospitalization due to CAD within the past one year?
5. Have you ever used any types of CAM (such as
patent herbal medicine, nutrient supplements,
exercise, herbal decoction, acupuncture, and others)
to treat your CAD? If yes, what are they?
6. How often did you use CAM to treat your CAD,
continuous use, intermittent use, or used once?
7. After the treatment of CAM for CAD, do you think
it is effective? Yes or No
8. Why do you take CAM to treat your CAD? (done
by CAM users) Fewer side effects; effective and mild
action; treating root cause; economic; health
preserving effect; without invasive examination;
others (please mark the one/s that best describe
your condition).
9. Why don’t you take CAM to treat your CAD? (done
by non-CAM users) Terrible taste; slower effectual
procedure; afraid of fake CAM products; doubt of
effect; inconvenient; afraid of acupuncture; others
(please mark the one/s that best describe your
condition).
10. Which types of CAM (e.g. patent herbal medicine,
nutrient supplements, exercise, herbal decoction,
acupuncture, and others) do you prefer, if you plan
to use it in the future for the management of CAD?
(done by non-CAM users) Note: Exercise refers to
walking, jogging, or other physical activities longer
than half an hour daily. Others refer to chiropractor
therapy, yoga, massage, meditation, etc.
Statistical analysis
Statistical analysis was performed with SPSS 13.0 software
(SPSS Inc., Chicago, IL, USA) for windows. Quantitative
data were expressed with mean ± standard deviation (SD)
and were analyzed using Student’s t-test. Categorical datawere described and analyzed using chi-square test. Logistic
regression was employed to explore factors associated
with the use of CAM as well as CAM use features in
Chinese medicine (CM) hospitals when significant dif-
ferences were found upon comparisons. A two tailed
P < 0.05 was considered statistically significant. Demo-
graphic characteristics were described with actual number
and percentages.
Results
Demographic characteristics of the patients
From May to July, 2009, a total of 600 questionnaires
were distributed at the outpatient cardiac clinics of the
four hospitals, and 546 patients with a diagnosis of CAD
responded with valid values and were included in the
present study. Characteristics of the included partici-
pants are detailed in Table 1. Fifty-four patients returned
questionnaires which had no valid information or were
non-legible and thus were excluded. In the sampled
population, 308 (56.4%) patients were male, 238 (43.6%)
patients were female; the age was 61.3 ± 9.2 years and
the disease duration was 9.6 ± 6.3 years. Regarding spe-
cific diagnosis of CAD, 33.9% were diagnosed with SA,
61.2% were diagnosed with UA, and 4.9% were diag-
nosed with MI. The majority of the patients were urban
citizens (74.2%). A greater portion of patients reported a
monthly household income higher than 4,000 RMB
(54.5%, one USD equaled 7 RMB at that time) and ≥ 2
concomitant diseases (55.9%), and had less than college
education (76.2%).
Comparisons between CAM use and non-CAM use groups
Based on whether the patient used CAM for the manage-
ment of CAD or not, 546 CAD patients were divided into
two groups: CAM use group (n = 377, 69%) and non-
CAM use group (n = 169, 31%). No significant differences
were found between CAM use and non-CAM use groups
in terms of gender, places of residence, education level,
and monthly household income, number of concomitant
diseases, treatment satisfaction, and disease perception.
Compared with the non-CAM use group, patients in the
CAM use group tended to be older (P < 0.01), have a lon-
ger disease duration (P = 0.02), and better current health
status as evaluated by SAQ (physical limitation: P = 0.01;
angina stability: P = 0.03; angina frequency: P = 0.01). Dur-
ing the past one year prior to study participation, 138/377
(36.6%) participants in the CAM use group as compared
to 82/169 (48.5%) participants in the non-CAM use group
experienced emergency admission (p < 0.01); 201/377
(53.3%) participants in the CAM use group as compared
to 106/169 (62.7%) participants in the non-CAM use
group were hospitalized at least once (p = 0.04). Compared
with non-CAM users, CAM users had significant lower
odds for emergency admission (OR = 0.61, 95% CI = 0.42 -
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CAD, Coronary artery disease; SA, Stable angina; UA, Unstable angina;
MI, Myocardial infarction; MHI, Monthly household income; PS, Less than
college education; CP, College and postgraduate; CAM, Complementary and
alternative medicine.
aOne US dollar equaled 7 RMB at that time.







Gender (male / female) 211 / 166 97 / 72 0.75
Age (years) 62.3 ± 10.2 59.5 ± 8.4 < 0.01
Disease duration (years) 8.6 ± 5.9 0.02
Places of residence
(urban/rural)
10.2 ± 7.6 123 / 46 0.62
MHIa 282 / 95 83 / 86 0.25
(< 4000 RMB / ≥ 4000
RMB)
165 / 212
Education level 127 / 42 0.70
(LC / CP) 289 / 88
Number of concomitant
disease
80 / 89 0.31
(≤ 2 / > 2) 161 / 216
Emergency admission 82 / 87 < 0.01
(yes / no) 138 / 239 (OR = 0.61, 95%
Cl = 0.42 - 0.89)
Hospitalization 106 / 63
(yes / no) 201 / 176 0.04
CAD-type (OR = 0.68, 95%




SAQ-physical limitation 20 51.8 ± 9.9 0.57
SAQ-angina stability 59.4 ± 10.8 38.9 ± 13.5
SAQ-angina frequency 54.5 ± 13.2 0.01
SAQ-treatment satisfaction 45.8 ± 14.2 65.8 ± 9.6 0.03
SAQ-disease perception 63.2 ± 14.7 47.6 ± 11.7 0.01
67.4 ± 11.1 0.12
0.3648.5 ± 12.6
CAM, Complementary and alternative medicine; MHI, Monthly household
income; LC, Less than college education; CP, College and postgraduate; SAQ,
Seattle Angina Questionnaire.
aOne US dollar equaled 7 RMB at that time.
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0.47 - 0.98, P = 0.04) within the past one year (see Table 2).
Prevalence, perceived effectiveness, reasons, and types of
CAM in CAD Management
Information of prevalence, perceived effectiveness, rea-
sons, and types of CAM in CAD management is provided
in Table 3. In the present study, 377 (69.1%) patients had
used at least one CAM therapy in treating CAD. Among
these 377 patients, 132 patients used it continuously; 286
patients considered CAM effective after CAM use. Patent
herbal medicine (90.7%) was the most commonly used
type. Patent herbal medicine refers to extracted condensed
pills or solutions from herbal medicine. The main reason
of CAM use was “few side effects” (49.6%); whereas “doubtof effect” (61.5%) was the main reason for non-use. The
majority of non-CAM users preferred patent herbal medi-
cine (81.1%) and nutrient supplements (66.3%) as the
future options if they would use CAM to treat CAD.
Differences of CAM use features between CM and WM
hospitals
Among these 377 patients who used CAM in the manage-
ment of their CAD, 257 (68.2%) were from CM hospitals
and 120 (31.8%) were from WM hospitals. As expected, the
proportion of CAM users in patients from CM hospitals
was significantly higher than that in WM hospitals (91.1%
vs. 45.5%, P < 0.01). In addition, significant differences were
Table 3 CAM use information and comparisons between CM and WM hospitals
Characteristics N CM hospital WM hospital P
Patients analyzed 546 282 264
CAM users (%) 377 (69.0) 257 (91.1) 120 (45.5) <0.01
Frequency
Continuous / intermittent or once 132 / 245 113 / 144 19 / 101 <0.01 (OR = 4.17, 95% CI = 2.41 - 7.22)
Patterns (%)
Chinese patent prescription 342 (90.7) 237 (69.3) 105 (30.7) 0.14
Nutrient supplements 204 (54.1) 136 (66.7) 68(33.3) 0.50
Exercise 129 (34.2) 81 (62.8) 48 (37.2) 0.11
Herbal decoction 280 (74.3) 224 (80.0) 56 (20.0) <0.01
Acupuncture 52 (13.8) 42 (80.8) 10 (19.2) 0.04
Others 18 (4.8) 13 (72.2) 5 (27.8) 0.71
Perceived effectiveness
Effective / ineffective 286 / 91 217 / 40 69 / 51 <0.01 (OR = 4.01, 95% CI = 2.45 - 6.58)
Reasons for CAM use (n = 377)
Fewer side effects 187 (49.6) 135 (72.2) 52 (27.8) 0.10
Effective and mild action 155 (41.1) 132 (85.2) 23 (14.8) <0.01
Treating root cause 106 (28.1) 97 (91.5) 9 (8.5) <0.01
Economic 79 (21.0) 58 (73.4) 21 (26.6) 0.26
Health preserving effect 37 (9.8) 27 (73.0) 10 (27.0) 0.51
Without invasive examination 30 (8.0) 18 (60) 12 (40) 0.32
Others 5 (1.3) 3 (60) 2 (40) 0.69
Reasons for non-CAM use (n = 169)
Terrible taste 59 (34.9) 12 (20.3) 47 (79.7) 0.14
Slower effectual procedure 77 (45.6) 9 (11.7) 68 (88.3) 0.30
Afraid of fake CAM products 29 (17.2) 4 (13.8) 25 (86.2) 0.87
Doubt of effect 104 (61.5) 2 (1.9) 102 (98.1) <0.01
Inconvenient 94 (55.6) 15 (16.0) 79 (84.0) 0.63
Afraid of acupuncture 23 (13.6) 4 (17.4) 19 (82.6) 0.71
Others 7 (4.1) 2 (28.6) 5 (71.4) 0.29
CAM preferred for future (n = 169)
Patent herbal medicine 137 (81.1) 23 (16.8) 114 (83.2) 0.13
Herbal decoction 54 (32.0) 12 (22.2) 42 (77.8) 0.06
Nutrient supplements 112 (66.3) 18 (16.1) 94 (83.9) 0.51
Exercise 36 (21.3) 8 (22.2) 28 (77.8) 0.15
Acupuncture 40 (23.7) 9 (22.5) 31 (77.5) 0.12
Others 13 (7.7) 4 (30.8) 9 (69.2) 0.09
CM, Chinese medical; WM, western medical; CAM, complementary and alternative medicine; OR, odds ratio; Cl, confidence interval.
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in terms of CAM use frequency (P < 0.01), types (herbal
decoction: P < 0.01; acupuncture: P = 0.04), perceived
effectiveness (P < 0.01), as well as reasons for CAM use
(effective: P < 0.01; treating the root cause: P < 0.01) and
non-CAM use (doubt of effect: P < 0.01). CAM users
from CM hospitals were more likely to be continuous users
(p < 0.01; OR = 4.17, 95% CI = 2.41 - 7.22), use herbaldecoction (p < 0.01) and acupuncture (p = 0.04), believe in
the efficacy of CAM treatments (p < 0.01; OR = 4.01, 95%
CI = 2.45 - 6.58) [see Table 3].
Discussion
This study provides one of the first comprehensive investi-
gations of CAM use in the Chinese population who were
diagnosed with CAD. The present study confirmed the
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than WM hospitals. The prevalence of CAM use among
Chinese patients with CAD was 69% in the present study.
It is higher than 4% - 61% in patients with cadiovascular
disease as shown by Grant et al. [20]. Patent herbal medi-
cine was the most commonly used CAM type (90.7% of
all CAM users) in the present study; whereas Grant et al.
[20] found that herbal medicines were used by only 2% to
46% patients with cardiac diseases. Upon a close examin-
ation, the data in the meta-analysis by Grant et al. [20]
were mainly based on studies performed in the United
States, Canada, and the United Kingdom. Thus, the cause
of differences may be due to different cultural back-
grounds. The results of the present study indicate that
physicians should be aware of the high prevalence of
CAM use, most likely herbal medicine use, in the Chinese
populations.
The present study indicates that old male patients
with UA are more likely to be CAM users and CAM
users are less likely to be hospitalized or experience
emergency admission in the past one year. These results
may be influenced by age, gender and/or disease duration.
Nonetheless, as CAM users were found to be older, have a
longer disease duration, and better current health status
than non-CAM users, we may hypothesize that CAM may
alleviate patients’ symptoms of CAD. This was confirmed
with patients’ perceived effectiveness of CAM in the
present study. However, evaluation of CAM effectiveness
in the management of CAD is beyond the purposes of the
present study and further high quality randomized control
trials are needed to explore the possible therapeutic effect-
iveness of CAM especially herbal medicine for CAD.
In the present study, CAM users were older; whereas
gender and education were not associated with CAM
use. Interestingly, in western populations, CAM users
were found to be more likely young, female, and with
higher education [11,13,15-19]. The variances may be re-
lated to the cultural background. During the past thirty
years, China has undergone tremendous westernization.
The young generation, as compared to the old gener-
ation, has been exposed more to western culture includ-
ing strong believes in western medicine and lack of
connection with traditional Chinese medicine. As trad-
itional Chinese medicine is the major type of CAM in
China and the sole type of medicine in some Chinese
rural areas, the old generation thus may tend to believe
and use CAM more than the young generation.
The present study demonstrated that a variety of
CAM therapies, including patent herbal medicine, herbal
decoction, acupuncture, and exercise, are prevalent and
widely used in patients with CAD from both CM and
WM hospitals in Beijing. Nonetheless, the small portion
of other CAM types indicates that unlike the results
provided by Prasad et al. [19], chiropractor, mind-bodytreatment, and massage are not commonly used by the
Chinese patients who were diagnosed with CAD. The
reasons may be: 1) chiropractic therapy is not common
in China and/or 2) Chinese patients don’t believe that
these forms of CAM work for CAD. Regarding the fre-
quency of use of specific types of CAM, the results of
the present study differ from the results reported by
Prasad et al. [19]. In the present study, patent herbal
medicine and herbal decoctions are the two most com-
monly used CAM therapies; whereas dietary supple-
ments and chiropractic therapy are the two most
commonly used in the study by Prasad et al. [19]. The
difference may be due to the strong cultural influence.
Compared with other types of CAM therapies, the Chin-
ese population including the Chinese physicians and Chin-
ese patients may believe that herbal medicine is more
effective for the management of CAD.
Decker et al. [18] reported that higher portions of pa-
tients with cardiovascular diseases were uninsured and
economically burdened. The present study found oppos-
ite results as the majority of the patients were urban citi-
zens and the majority of patients reported a monthly
household income higher than 4,000 RMB. The possible
reason for the results may be due to the location of the
sampled hospitals which locate in urban Beijing. In order
to test the difference of economic statuses of CAM use
populations, hospitals locate in the suburb or country-
side should be included. The present study also found
that the majority of CAM users tend to use CAM inter-
mittently or once. As the majority of CAM users in the
present study had higher monthly house hold income,
causes of intermittent use may be due to cultural believes
(Chinese people may believe intermittent use may be more
effective) or physician instructions or just compliance in
addition to economic costs. The main cause of CAM use
in the present study was patients’ belief of few side effects
whereas the main cause of non-CAM use was doubt of
effects. Nonetheless, modern research studies report
that CAM therapies like herbal medicine does have side
effects [26], and certain CAM therapy have been shown
to be effective in the management of certain disorders,
such as acupuncture for pain [27]. Consequently, in
order to correct the misunderstandings of CAM of the
general public, physicians should give the Chinese patients
a more detailed introduction of CAM therapy from an
evidence-based approach upon clinical treatment of CAD.
Limitations
Although the study included 377 CAM users which may
be sufficient for the analysis of features of CAM use in
patients with CAD in Beijing, patients were collected
only in the cardiac outpatient clinics of four tertiary-
level hospitals out of 35 tertiary-level hospitals. Patients
with CAD relying solely on other CAM therapies besides
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present study. Therefore, the features captured in the
present study may not well characterize the features of
CAM use in patients diagnosed with CAD in Beijing. Pa-
tients were asked to complete a questionnaire through
recalling the use of CAM in the past years; recall bias
may exist during the data collection process. In addition,
the validity and reliability of Part One of the question-
naire used in the study require further examination.
Conclusions
The present study suggested a group of significant factors
which could influence the use of CAM in Chinese patients
with CAD. CAM use patterns differ in patients from CM
and WM hospitals. The study may help clinicians under-
stand the preferred options and perspectives of CAD
treatments by the Chinese patients.
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